Task: Answer the MCQ question.
Question: Which drug exhibits a 5.236% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: Cc1nc2ccccc2c(=O)n1/N=C/c1ccc(C(C)C)cc1
b: CN(C)c1ccc(-c2nnc(SCC3CCCO3)n2C)cc1
c: COC(=O)c1cc2c(ccn2-c2ccc(F)cc2)n1CC(=O)OC(C)C
Answer: b. CN(C)c1ccc(-c2nnc(SCC3CCCO3)n2C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)c1ccc(-c2nnc(SCC3CCCO3)n2C)cc1
CN(C)c1ccc(-c2nnc(SCC3CCCO3)n2C)cc1
N,N-dimethyl-4-[4-methyl-5-(oxolan-2-ylmethylsulfanyl)-1,2,4-triazol-3-yl]aniline